Coronavirus Update
To learn more about what the biopharmaceutical industry is doing to combat the virus and for a host of information and helpful resources (FAQ’s, CDC Information Hub, Safety Tips, etc.)
Charleston, W.Va. (June 6, 2018) – According to an industry-wide study released on June 5th on the economic impact of the U.S. bioscience industries, “West Virginia’s bioscience industry is growing rapidly...State bioscience firms grew their employment base by 14 percent from 2014 through 2016, well outpacing national growth (4.4 percent) to reach nearly 8,000 total industry jobs”.
The study, entitled “Investment, Innovation and Job Creation in a Growing U.S. Bioscience Industry 2018”, was conducted by the Biotechnology Innovation Organization (BIO) – the national trade association representing the bioscience industries.
According to the report:
Bryan Brown, executive director of the West Virginia Bioscience Association, said, “It’s remarkable to see West Virginia’s bio industries growing over the past two years given the economic challenges facing the state. This is a testament to the skill and perseverance of the entrepreneurs and researchers – both in private companies and on university campuses – who are creating innovative products and technologies in the Mountain State.”
Brown said companies like Alcon in Huntington and Mylan in Morgantown, are helping drive growth in this sector, as are state biotech companies like Randox, Cordgenics, Valtari Bio, Progenesis, Microbiological Consultants and New River Labs. Additionally, West Virginia University and Marshall University, among other state colleges, continue to grow their research and development programs.
The BIO report includes individual profiles for all 50 states, the District of Columbia and Puerto Rico, and can be found on the BIO website at bio.org/jobs2018.